Electronic Patient Portal Activation and Outcomes Among Pediatric Patients with Asthma

Elsevier

Available online 21 March 2023

The Journal of Allergy and Clinical Immunology: In PracticeAuthor links open overlay panelDariush Kafashzadeh MD 1, Kaitlin Hall MD 1, Cenan Pirani PhD 2, Peter G. Szilagyi MD 1, Lucia Chen MS 2, Mindy K. Ross MD 1Show more

Recommended articles

Dariush Kafashzadeh: [email protected]

Kaitlin Hall: [email protected]

Cenan Pirani: [email protected]

Peter G. Szilagyi: [email protected]

Lucia Chen: [email protected]

Declaration of all sources of funding: Kafashzadeh: UCLA employment; Hall: UCLA employment, Health Resources and Services Administration (HRSA) Ruth L. Kirschstein Institutional National Research Service Award (NSRA) T32HP19001;

Pirani: UCLA employment, National Center for Advancing Translational Science (NCATS) of the National Institutes of Health (NIH) under the UCLA Clinical and Translational Science Institute grant number UL1TR001881; Szilagyi: UCLA employment, NIH 1 R01 AI13502901

Chen: UCLA employment, NCATS NIH UL1TR001881; Ross: UCLA employment, National Heart, Lung, and Blood Institute (NHLBI) NIH 1K23HL148502-01A1

Clinical Implications Statement: We found portal use in pediatric asthma patients was more likely to be by historically-advantaged groups; and English-language preferred activated portal users were less likely to experience asthma emergency room visits and hospitalizations than non-users when controlling for other characteristics

© 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology

Recommended articlesArticle Metrics

留言 (0)

沒有登入
gif